MX2009010396A - Cubiertas polimericas biodegradables para implantes de mama. - Google Patents

Cubiertas polimericas biodegradables para implantes de mama.

Info

Publication number
MX2009010396A
MX2009010396A MX2009010396A MX2009010396A MX2009010396A MX 2009010396 A MX2009010396 A MX 2009010396A MX 2009010396 A MX2009010396 A MX 2009010396A MX 2009010396 A MX2009010396 A MX 2009010396A MX 2009010396 A MX2009010396 A MX 2009010396A
Authority
MX
Mexico
Prior art keywords
biodegradable
breast
implant
breast implants
coverings
Prior art date
Application number
MX2009010396A
Other languages
English (en)
Inventor
Arikha Moses
Satish Pulapura
Qing Ge
Sarita Nethula
Archana Rajaram
Original Assignee
Tyrx Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tyrx Pharma Inc filed Critical Tyrx Pharma Inc
Publication of MX2009010396A publication Critical patent/MX2009010396A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/12—Mammary prostheses and implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/14—Dipping a core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Se proporciona una cubierta flexible biodegradable para un implante de mama, que comprende una o más capas poliméricas biodegradables dimensionadas y configuradas para cubrir al menos una parte del implante de mama. El implante puede insertarse en una abertura de la cubierta inmediatamente antes de la cirugía, pero están contempladas configuraciones y tiempos de inserción alternos, así como dispositivos de tipo abierto o de tipo lámina. Las cubiertas opcionalmente pueden contener uno o más fármacos para su administración en el sitio quirúrgico, particularmente para tratar o prevenir infección, dolor, inflamación, contractura capsular, cicatrices u otras complicaciones asociadas con el aumento del busto o reconstrucción del busto.
MX2009010396A 2007-03-29 2008-03-28 Cubiertas polimericas biodegradables para implantes de mama. MX2009010396A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90896007P 2007-03-29 2007-03-29
US98310807P 2007-10-26 2007-10-26
PCT/US2008/058652 WO2008121816A2 (en) 2007-03-29 2008-03-28 Biodegradable, polymer coverings for breast implants

Publications (1)

Publication Number Publication Date
MX2009010396A true MX2009010396A (es) 2009-12-02

Family

ID=39794766

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010396A MX2009010396A (es) 2007-03-29 2008-03-28 Cubiertas polimericas biodegradables para implantes de mama.

Country Status (7)

Country Link
US (1) US8911765B2 (es)
EP (1) EP2129339B1 (es)
JP (2) JP5400029B2 (es)
AU (1) AU2008232682B2 (es)
CA (1) CA2682190C (es)
MX (1) MX2009010396A (es)
WO (1) WO2008121816A2 (es)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2625264C (en) 2005-10-13 2015-12-15 Synthes (U.S.A.) Drug-impregnated sleeve for a medical implant
US8315700B2 (en) 2006-02-08 2012-11-20 Tyrx, Inc. Preventing biofilm formation on implantable medical devices
US8591531B2 (en) 2006-02-08 2013-11-26 Tyrx, Inc. Mesh pouches for implantable medical devices
MX2008010126A (es) 2006-02-08 2010-02-22 Tyrx Pharma Inc Protesis de malla temporalmente rigidizadas.
US7722665B2 (en) * 2006-07-07 2010-05-25 Graft Technologies, Inc. System and method for providing a graft in a vascular environment
US7846728B2 (en) * 2006-10-13 2010-12-07 BioStruxs, LLC Tissue engineering in vivo with vascularized scaffolds
US9023114B2 (en) 2006-11-06 2015-05-05 Tyrx, Inc. Resorbable pouches for implantable medical devices
WO2008137807A1 (en) * 2007-05-02 2008-11-13 Tyrx Pharma, Inc. Dihydroxybenzoate polymers and uses thereof
US8313527B2 (en) 2007-11-05 2012-11-20 Allergan, Inc. Soft prosthesis shell texturing method
US8211173B2 (en) * 2007-12-07 2012-07-03 Keller Medical, Inc. Apparatus and process for delivering a silicone prosthesis into a surgical pocket
US20090149953A1 (en) * 2007-12-10 2009-06-11 Schuessler David J Form stable breast implant sizer and method of use
US8506627B2 (en) 2008-08-13 2013-08-13 Allergan, Inc. Soft filled prosthesis shell with discrete fixation surfaces
US9050184B2 (en) 2008-08-13 2015-06-09 Allergan, Inc. Dual plane breast implant
US8419793B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US8420153B2 (en) 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US20100198278A1 (en) * 2009-02-02 2010-08-05 Medtronic, Inc. Composite antimicrobial accessory including a membrane layer and a porous layer
US8092443B2 (en) 2009-03-30 2012-01-10 Medtronic, Inc. Element for implantation with medical device
US9078712B2 (en) 2009-04-15 2015-07-14 Warsaw Orthopedic, Inc. Preformed drug-eluting device to be affixed to an anterior spinal plate
US8206443B2 (en) 2009-04-29 2012-06-26 Keller Medical, Inc. Fail-safe silicone breast implant delivery device
US20100280610A1 (en) 2009-04-29 2010-11-04 Keller Medical, Inc. Silicone breast implant delivery
US8858983B2 (en) * 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
US20100288291A1 (en) * 2009-05-15 2010-11-18 Friedman Michelle A Method for preventing or treating pressure sores
DE202009007115U1 (de) * 2009-05-18 2010-06-02 Amoena Medizin-Orthopädie-Technik GmbH Brustprothese
US9839628B2 (en) * 2009-06-01 2017-12-12 Tyrx, Inc. Compositions and methods for preventing sternal wound infections
US8986377B2 (en) 2009-07-21 2015-03-24 Lifecell Corporation Graft materials for surgical breast procedures
US20110029076A1 (en) * 2009-07-30 2011-02-03 Paletta John D Breast Implant Therapeutic Delivery System
US20110106249A1 (en) * 2009-09-02 2011-05-05 Hilton Becker Self supporting and forming breast implant and method for forming and supporting an implant in a human body
US20110082545A1 (en) * 2009-10-01 2011-04-07 Lipose Corporation Drug eluting breast implant cover or coating
US8409279B2 (en) * 2009-10-01 2013-04-02 Lipose Corporation Breast implant implantation method and apparatus
US20110093069A1 (en) 2009-10-16 2011-04-21 Allergan, Inc. Implants and methdos for manufacturing same
CA2787824A1 (en) 2010-01-28 2011-08-04 Allergan, Inc. Open celled foams, implants including them and processes for making same
US9044897B2 (en) 2010-09-28 2015-06-02 Allergan, Inc. Porous materials, methods of making and uses
US9138308B2 (en) 2010-02-03 2015-09-22 Apollo Endosurgery, Inc. Mucosal tissue adhesion via textured surface
US8877822B2 (en) 2010-09-28 2014-11-04 Allergan, Inc. Porogen compositions, methods of making and uses
US9072821B2 (en) 2010-02-05 2015-07-07 Allergan, Inc. Biocompatible structures and compositions
US8889751B2 (en) 2010-09-28 2014-11-18 Allergan, Inc. Porous materials, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
US9205577B2 (en) 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US8679570B2 (en) 2010-04-27 2014-03-25 Allergan, Inc. Foam-like materials and methods for producing same
US20110301706A1 (en) * 2010-04-29 2011-12-08 BioStruxs, LLC Breast Reconstruction Device And Methods
HUE031363T2 (hu) 2010-05-11 2017-07-28 Allergan Inc Porogén készítmények, az elõállításukra szolgáló eljárások és felhasználásuk
US11202853B2 (en) 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
US8679279B2 (en) 2010-11-16 2014-03-25 Allergan, Inc. Methods for creating foam-like texture
US8546458B2 (en) 2010-12-07 2013-10-01 Allergan, Inc. Process for texturing materials
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
ES2915842T3 (es) 2011-03-09 2022-06-27 Tepha Inc Sistemas para mastopexia
US9295809B2 (en) 2011-03-24 2016-03-29 C. R. Bard, Inc. Fixation and protection of an implanted medical device
KR101288115B1 (ko) * 2011-05-04 2013-07-19 유원석 생체분해성 고분자가 코팅된 실리콘 임플란트 재료 및 그 제조방법
WO2013033168A1 (en) * 2011-08-30 2013-03-07 Mast Biosurgery Ag Polyactic acid/alginate containing surgical barrier
US8801782B2 (en) 2011-12-15 2014-08-12 Allergan, Inc. Surgical methods for breast reconstruction or augmentation
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
EP3400900B1 (en) 2012-01-13 2020-05-20 LifeCell Corporation Methods of manufacturing breast prostheses
US9642697B2 (en) * 2012-04-24 2017-05-09 Snu R&Db Foundation Breast prosthesis allowing controlled release of drug and production method for same
US8808372B2 (en) * 2012-04-27 2014-08-19 Cold Winter Solutions, L.L.C. Breast implant spacers for the treatment of periprosthetic breast implant infections
ES2875895T3 (es) * 2012-06-05 2021-11-11 Allergan Inc Implante de mama en dos planos
BR112014031707A2 (pt) 2012-06-21 2017-06-27 Lifecell Corp prótese; método para fabricar uma prótese implantável; e método para tratamento
ITTV20120038U1 (it) 2012-09-17 2014-03-18 Deco Med S R L Dispositivo medico, particolarmente per la ricostruzione mammaria.
US10820984B2 (en) 2012-11-14 2020-11-03 ImplantADJUST, LLC Implant with elastomeric membrane and methods of fabrication thereof
WO2014093669A1 (en) 2012-12-13 2014-06-19 Allergan, Inc. Device and method for making a variable surface breast implant
US20160081858A1 (en) * 2013-04-16 2016-03-24 Duke University Compositions and Methods for the Prevention of Scarring and/or Promotion of Wound Healing
WO2014172572A1 (en) 2013-04-18 2014-10-23 Board Of Regents, The University Of Texas System Antimicrobial wraps for medical implants
US20160144067A1 (en) 2013-06-21 2016-05-26 DePuy Synthes Products, Inc. Films and methods of manufacture
US9532867B2 (en) 2013-07-11 2017-01-03 Tepha, Inc. Absorbable implants for plastic surgery
US10092392B2 (en) 2014-05-16 2018-10-09 Allergan, Inc. Textured breast implant and methods of making same
WO2015176014A1 (en) 2014-05-16 2015-11-19 Allergan, Inc. Soft filled prosthesis shell with variable texture
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
JP6800888B2 (ja) 2015-05-15 2020-12-16 ライフセル コーポレーションＬｉｆｅＣｅｌｌ Ｃｏｒｐｏｒａｔｉｏｎ 形成外科用組織マトリックス
EP3337427A1 (en) 2015-08-21 2018-06-27 Lifecell Corporation Breast treatment device
USD836778S1 (en) 2015-10-09 2018-12-25 Tepha, Inc. Three dimensional mastopexy implant
US10765782B2 (en) * 2016-05-03 2020-09-08 Medtronic, Inc. Hemostatic devices and methods of use
US10420864B2 (en) * 2016-05-03 2019-09-24 Medtronic, Inc. Hemostatic devices and methods of use
US10980922B2 (en) 2016-05-03 2021-04-20 Medtronic, Inc. Hemostatic devices and methods of use
US10933174B2 (en) 2016-05-03 2021-03-02 Medtronic, Inc. Hemostatic devices and methods of use
US10939901B2 (en) 2016-05-04 2021-03-09 Medtronic, Inc. Customizable anchorage devices and methods of use
EP3506854B1 (en) 2016-08-31 2020-08-19 LifeCell Corporation Breast treatment device
JP2019536503A (ja) * 2016-09-28 2019-12-19 オーキッド・メディカル・プライベイト・リミテッドＯｒｃｈｉｄ Ｍｅｄｉｃａｌ Ｐｔｅ Ｌｔｄ インプラントのための弾性生体吸収性エンケースメント
US10722335B1 (en) 2016-11-15 2020-07-28 Proximate Concepts Llc Device for the delivery of a prosthetic implant and method of use thereof
US9925028B1 (en) 2016-11-15 2018-03-27 Proximate Concepts Llc Device for the delivery of a prosthetic implant and method of use thereof
US11439797B2 (en) 2017-02-10 2022-09-13 Medtronic Advanced Energy Llc. Surgical drain system and container
CA3078555A1 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
DE102017009989A1 (de) 2017-10-26 2019-05-02 Carl Freudenberg Kg Biokompatibles Verbundmaterial zum Einbringen in einen menschlichen Körper
EP3494926A1 (de) * 2017-12-05 2019-06-12 Repuls Lichtmedizinteckhnik GmbH Implantat mit reservoir
EP3727198B1 (en) * 2017-12-22 2024-01-17 Polynovo Biomaterials Pty Limited Soft tissue implant pocket
USD889655S1 (en) 2018-02-09 2020-07-07 Tepha, Inc. Three dimensional mastopexy implant
WO2019156870A2 (en) 2018-02-09 2019-08-15 Tepha, Inc. Full contour breast implant
USD889654S1 (en) 2018-02-09 2020-07-07 Tepha, Inc. Three dimensional mastopexy implant
KR20210009302A (ko) 2018-03-13 2021-01-26 플라비오 나니 인공삽입물을 위한 생물학의 또는 생합성의 재료로 제조되고 인공삽입물에 고정을 위한 시스템을 포함하는 메쉬 또는 멤브레인 커버링, 및 해당하는 제조 방법
USD892329S1 (en) 2018-07-03 2020-08-04 Tepha, Inc. Three dimensional mastopexy implant
USD908214S1 (en) 2018-07-10 2021-01-19 United States Endoscopy Group, Inc. Tip protector
EP3860506A4 (en) 2018-10-02 2022-06-29 Tepha, Inc. Medical devices to limit movement of breast implants
US11612754B2 (en) 2018-12-21 2023-03-28 Tepha, Inc. Resorbable nonwoven pouches for medical device implants
US11298220B2 (en) 2019-05-03 2022-04-12 Lifecell Corporation Breast treatment device
US11850135B2 (en) 2019-08-01 2023-12-26 Paul H. Rosenberg Family Trust Prosthetic implant delivery device utilizing surface active agents
CN114980838A (zh) 2019-11-25 2022-08-30 特法公司 限制乳房植入物移动的乳房植入物包裹物和相关方法
US11602426B2 (en) * 2020-10-23 2023-03-14 Andrew Weems Void occlusion device
CA3238256A1 (en) * 2021-11-18 2023-05-25 Joel Rosenblatt Antimicrobial wraps for medical implants

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298997A (en) 1979-10-23 1981-11-10 Rybka F James Device for inhibiting the formation of fibrous capsular contractures in silicone breast implants and method
US4539234A (en) 1981-05-27 1985-09-03 Unitika Ltd. Urethral catheter capable of preventing urinary tract infection and process for producing the same
DE3329733A1 (de) * 1983-08-17 1985-03-07 Johannes Dr.med. 6500 Mainz Reinmüller Kunststoff-implantat
US4648880A (en) 1984-08-30 1987-03-10 Daniel Brauman Implantable prosthetic devices
AU617667B2 (en) 1986-11-04 1991-12-05 Allergan, Inc. Open-cell, silicone-elastomer medical implant and method for making
US4846844A (en) 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
US5282856A (en) 1987-12-22 1994-02-01 Ledergerber Walter J Implantable prosthetic device
US5587507A (en) 1995-03-31 1996-12-24 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US5216115A (en) 1990-06-12 1993-06-01 Rutgers, The State University Of New Jersey Polyarylate containing derivatives of the natural amino acid L-tyrosine
US5099060A (en) 1990-06-12 1992-03-24 Rutgers, The State University Of New Jersey Synthesis of amino acid-derived bioerodible polymers
USRE37160E1 (en) 1990-06-12 2001-05-01 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US5250020A (en) * 1991-09-12 1993-10-05 Mentor Corporation Unitary inflatable penile prosthesis
US5376117A (en) 1991-10-25 1994-12-27 Corvita Corporation Breast prostheses
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5217493A (en) 1992-03-11 1993-06-08 Board Of Regents, The University Of Texas System Antibacterial coated medical implants
US5766246A (en) 1992-05-20 1998-06-16 C. R. Bard, Inc. Implantable prosthesis and method and apparatus for loading and delivering an implantable prothesis
AU686206B2 (en) 1993-07-12 1998-02-05 Regents Of The University Of California, The Soft tissue augmentation apparatus
US5624704A (en) 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
US5630844A (en) 1995-06-07 1997-05-20 Novamed Medical Products Manufacturing, Inc. Biocompatible hydrophobic laminate with thermoplastic elastomer layer
US5877224A (en) 1995-07-28 1999-03-02 Rutgers, The State University Of New Jersey Polymeric drug formulations
US6558686B1 (en) 1995-11-08 2003-05-06 Baylor College Of Medicine Method of coating medical devices with a combination of antiseptics and antiseptic coating therefor
US5658995A (en) 1995-11-27 1997-08-19 Rutgers, The State University Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide)
EP1704878B1 (en) 1995-12-18 2013-04-10 AngioDevice International GmbH Crosslinked polymer compositions and methods for their use
US6143037A (en) 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
US6319492B1 (en) 1996-11-27 2001-11-20 Rutgers, The State University Copolymers of tyrosine-based polyarylates and poly(alkylene oxides)
US6048521A (en) 1997-11-07 2000-04-11 Rutgers, The State University Copolymers of tyrosine-based polyarlates and poly(alkylene oxides)
US6120491A (en) * 1997-11-07 2000-09-19 The State University Rutgers Biodegradable, anionic polymers derived from the amino acid L-tyrosine
AU1070899A (en) 1997-10-10 1999-05-03 Corbitt, John D. Jr. Breast implant
US6602497B1 (en) 1997-11-07 2003-08-05 Rutgers, The State University Strictly alternating poly(alkylene oxide ether) copolymers
US6475477B1 (en) 1997-11-07 2002-11-05 Rutgers, The State University Radio-opaque polymer biomaterials
WO1999052962A1 (en) 1998-04-13 1999-10-21 Rutgers, The State University The construction of copolymer libraries
US6298998B1 (en) 1998-07-06 2001-10-09 Bridgestone/Firestone Inc. Supportive pin rack for green tire storage
US20050147690A1 (en) 1998-09-25 2005-07-07 Masters David B. Biocompatible protein particles, particle devices and methods thereof
US6382526B1 (en) 1998-10-01 2002-05-07 The University Of Akron Process and apparatus for the production of nanofibers
US6544287B1 (en) * 1998-12-11 2003-04-08 Gerald W. Johnson Solid filled implants
EP2305324B1 (en) 1999-03-25 2014-09-17 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US6103255A (en) 1999-04-16 2000-08-15 Rutgers, The State University Porous polymer scaffolds for tissue engineering
FI19991852A (fi) 1999-09-01 2001-03-01 Yli Urpo Antti Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
WO2001049249A2 (en) 1999-12-31 2001-07-12 Rutgers, The State University Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
WO2001049311A1 (en) 1999-12-31 2001-07-12 Rutgers, The State University Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
US7521061B2 (en) 1999-12-31 2009-04-21 Rutgers, The State University Of New Jersey Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
US7510566B2 (en) 2000-05-19 2009-03-31 Coapt Systems, Inc. Multi-point tissue tension distribution device and method, a chin lift variation
US7025063B2 (en) 2000-09-07 2006-04-11 Ams Research Corporation Coated sling material
EP1247537A1 (en) 2001-04-04 2002-10-09 Isotis B.V. Coating for medical devices
US6656488B2 (en) 2001-04-11 2003-12-02 Ethicon Endo-Surgery, Inc. Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering
JP2003006813A (ja) 2001-06-20 2003-01-10 Shinka Jitsugyo Kk 薄膜磁気ヘッドおよびその製造方法
US6913626B2 (en) 2001-08-14 2005-07-05 Mcghan Jim J. Medical implant having bioabsorbable textured surface
NL1019023C2 (nl) * 2001-09-24 2003-03-25 Mentor Medical Systems B V Inrichting en werkwijze voor het vervaardigen van een siliconen omhulsel voor een borstimplantaat.
US6887270B2 (en) 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
WO2003071870A1 (en) 2002-02-26 2003-09-04 Schlesinger Stephen L Use of leukotriene receptor antagonist for treatment of scarring
AU2003217988A1 (en) 2002-03-07 2003-09-22 Dreamwell, Ltd. Low-profile mattress
WO2003079985A2 (en) 2002-03-18 2003-10-02 Carnegie Mellon University Method and apparatus for preparing biomimetic scaffold
US7271234B2 (en) 2002-04-24 2007-09-18 Rutgers, The State University Of New Jersey Polyarylates for drug delivery and tissue engineering
AU2003234670B2 (en) 2002-05-24 2010-06-10 Angiotech International Ag Compositions and methods for coating medical implants
US6916483B2 (en) 2002-07-22 2005-07-12 Biodynamics, Llc Bioabsorbable plugs containing drugs
EP1545389B1 (en) * 2002-07-31 2020-04-22 Mast Biosurgery AG Apparatus for preventing adhesions between an implant and surrounding tissues
US20050163821A1 (en) 2002-08-02 2005-07-28 Hsing-Wen Sung Drug-eluting Biodegradable Stent and Delivery Means
JP4296399B2 (ja) 2002-09-03 2009-07-15 真実 仁尾 乳房メッシュインプラント
US20050079365A1 (en) 2002-10-09 2005-04-14 Widenhouse Christopher W. Method for the surface modification of silicone surfaces
WO2004069029A2 (en) 2003-01-29 2004-08-19 Children's Medical Center Corporation Prevention of surgical adhesions using selective cox-2 inhibitors
EP1608377B1 (en) * 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US20040197374A1 (en) * 2003-04-02 2004-10-07 Alireza Rezania Implantable pouch seeded with insulin-producing cells to treat diabetes
US7617007B2 (en) 2003-06-04 2009-11-10 Synecor Llc Method and apparatus for retaining medical implants within body vessels
US6974862B2 (en) 2003-06-20 2005-12-13 Kensey Nash Corporation High density fibrous polymers suitable for implant
JP4296405B2 (ja) 2003-11-04 2009-07-15 真実 仁尾 乳房メッシュインプラント
US20050208095A1 (en) 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
JP2007516742A (ja) * 2003-11-20 2007-06-28 アンジオテック インターナショナル アーゲー 電気装置と瘢痕化抑制剤
US20050209664A1 (en) 2003-11-20 2005-09-22 Angiotech International Ag Electrical devices and anti-scarring agents
US8691258B2 (en) 2003-12-12 2014-04-08 Medtronic, Inc. Anti-infective medical device
US20050220841A1 (en) 2004-04-06 2005-10-06 Dewitt David M Coating compositions for bioactive agents
US20060025852A1 (en) 2004-08-02 2006-02-02 Armstrong Joseph R Bioabsorbable self-expanding endolumenal devices
WO2006020922A2 (en) * 2004-08-13 2006-02-23 Mast Biosurgery Ag Surgical prosthesis having biodegradable and nonbiodegradable regions
US20060095134A1 (en) 2004-10-28 2006-05-04 Sdgi Holdings, Inc. Materials, devices and methods for implantation of transformable implants
US20060115449A1 (en) 2004-11-30 2006-06-01 Advanced Cardiovascular Systems, Inc. Bioabsorbable, biobeneficial, tyrosine-based polymers for use in drug eluting stent coatings
US20060154063A1 (en) * 2004-12-15 2006-07-13 Kazutoshi Fujihara Nanofiber construct and method of preparing thereof
US20070196421A1 (en) * 2005-10-03 2007-08-23 Hunter William L Soft tissue implants and drug combination compositions, and use thereof
US8153837B2 (en) 2005-11-03 2012-04-10 Tyrx, Inc. Resorbable phenolic polymers
US8591531B2 (en) 2006-02-08 2013-11-26 Tyrx, Inc. Mesh pouches for implantable medical devices
US8315700B2 (en) * 2006-02-08 2012-11-20 Tyrx, Inc. Preventing biofilm formation on implantable medical devices
MX2008010126A (es) 2006-02-08 2010-02-22 Tyrx Pharma Inc Protesis de malla temporalmente rigidizadas.
US20070299155A1 (en) * 2006-06-09 2007-12-27 Medivas, Llc Biodegradable polymer adhesion barriers
US9023114B2 (en) * 2006-11-06 2015-05-05 Tyrx, Inc. Resorbable pouches for implantable medical devices
WO2008075398A2 (en) * 2006-12-20 2008-06-26 Di.Pro S.A.S. Di Buemi Enrico & C. Surgical prosthesis including a woven mesh for surgical use and a method of manufacturing thereof
WO2008137807A1 (en) 2007-05-02 2008-11-13 Tyrx Pharma, Inc. Dihydroxybenzoate polymers and uses thereof

Also Published As

Publication number Publication date
CA2682190C (en) 2015-01-27
JP5774074B2 (ja) 2015-09-02
EP2129339A2 (en) 2009-12-09
JP5400029B2 (ja) 2014-01-29
EP2129339A4 (en) 2013-09-04
WO2008121816A2 (en) 2008-10-09
US8911765B2 (en) 2014-12-16
CA2682190A1 (en) 2008-10-09
JP2010522627A (ja) 2010-07-08
AU2008232682A1 (en) 2008-10-09
JP2014014720A (ja) 2014-01-30
WO2008121816A3 (en) 2008-12-18
US20080241212A1 (en) 2008-10-02
AU2008232682B2 (en) 2013-03-21
EP2129339B1 (en) 2015-03-04

Similar Documents

Publication Publication Date Title
MX2009010396A (es) Cubiertas polimericas biodegradables para implantes de mama.
WO2011000970A3 (en) Bone graft and biocomposite for prosthetic dentistry
WO2008111078A3 (en) Soft tissue fixation devices
EP2049023A4 (en) APPARATUS AND METHOD FOR MANIPULATING OR RETRACTING ANATOMIC FABRICS AND STRUCTURES
CA2749778C (en) A device, system and method for treating obesity
WO2008043044A8 (en) Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery
NZ598691A (en) Prosthetic device and method of manufacturing the same
WO2006023130A3 (en) Biodegradable controlled release bioactive agent delivery device
WO2009058990A3 (en) Vascular closure device
WO2008057328A3 (en) Tissue separating device with reinforced support for anchoring mechanisms
WO2009011882A3 (en) Endoscopic implant system and method
WO2008016919A3 (en) Mastopexy and breast reconstruction prostheses and method
WO2006110197A3 (en) Polymer biodegradable medical device
WO2008057845A3 (en) Bioabsorbable implantable material fortified with antibiotics for localized delivery of drugs
MX2009004819A (es) Bolsas reabsorbibles para dispositivos medicos implantables.
NZ585547A (en) Biocompatible biodegradable fumagillin analog conjugates
WO2009009415A3 (en) Disk fusion implant
MX2010000060A (es) Malla implantable para trauma musculoesqueletal, reconstruccion ortopedica y reparacion de tejido blando.
EP2179753A3 (en) Hemostatic implant
BR112012013043A2 (pt) implantes de mama e métodos de fabricação
ATE468827T1 (de) Prothese zur behandlung der harninkontinenz
EP2168610A3 (en) Reactive surgical implant
WO2011065979A3 (en) Adhesive delivery devices, systems and methods
WO2010030076A3 (ko) 골조직 이식을 위한 주사기용 본 인퓨저
WO2009006390A3 (en) Drug-eluting staples prosthesis

Legal Events

Date Code Title Description
FA Abandonment or withdrawal